TMS Therapy Offers Hope for Senior Adults With Depression
By Sutton Place TMS | May 7, 2017
Late-life depression (LLD) is a frequent complication of the aging process, occurring in up to 5% of senior adults and in a higher proportion of subjects with coexistent medical illnesses.
The average senior adult is taking over 5 prescription medications per day, with the amount rising significantly for those who are ambulatory and in nursing homes. There is an imperative need to develop new treatment strategies for LLD, primarily with non-medication treatments. Non-invasive brain stimulation techniques such as transcranial magnetic stimulation (TMS) are a safe, FDA-cleared and a Medicare covered service.
At the Clinical TMS Society Annual Meeting, held in conjunction with the American Psychiatric Association (APA), Sutton Place TMS presented data showing the efficacy of TMS therapy in treating those ages 65 and older.
Clinical Results of Forty-Two Senior Adults:
Forty-two senior adults’ mental health progress was tracked over a 6-week period while receiving TMS therapy for depression. The average patient age was 72 and 64% were diagnosed with severe depression. Of the forty-two patients, 69% had a significant improvement in symptoms and 59.5% were shown to achieved remission.